INVEST IN AFRICA NOW

Set-up your Business in Africa's Key Industrial Zones

Name *

Email *

Phone No. *

Investment Sector

Investment Opportunity

Investment Budget (USD)

How may we assist you?

*Note: Name, Email and Phone Number are mandatory.

I agree to the AFI privacy policy.*

I agree to receive e-communications from AFI.

THANK YOU

Our team will get back to you shortly.

Home / Democratic Republic of Congo / CIP / Pharmaceuticals

Pharmaceuticals

CIP | Special Economic Zone in Kinshasa

The DRC is the largest importer of pharmaceutical products in Central Africa. Imported value: In 2022, Democratic Republic of the Congo imported over $236M in Packaged Medicaments (OEC) and $154M in Vaccines, blood, antisera, & toxins.

61%

Import Reliance

Untapped Potential: Invest in Pharma Sector in CIP, Democratic Republic of Congo

Total demand for packaged medicines in Africa amounts to around $18 billion a year, of which 61% is imported and 36% locally produced. Increased spending in Africa, a wider market base , a maturing business environment and increasing generalization are expected to drive growth in the pharmaceutical industry, forecast at a CAGR of 5.13% between 2022 and 2027 (UNIDO).

In the DRC, regulatory reforms are being taken by the Government to spur the growth of the pharmaceutical industry. The Government has recently restricted the imports of products of specific anti-malaria, anti-inflammatory medications, vitamins. We believe that the Kin-Malebo region stands as a favorable gateway for investors seeking to capitalize on this alluring investment opportunity, by providing support for the establishment of their factories, obtaining approvals, and sales on the local market.

FACILITIES IN CIP Pharmaceuticals